NCT02108366View on ClinicalTrials.gov

Treatment of Severe Influenza A Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

June 30, 2018

Conditions
Influenza, Human
Interventions
DRUG

Celecoxib

Celecoxib 200mg daily

DRUG

Oseltamivir

Oseltamivir 75mg bid

DRUG

Placebo

Placebo capsule identical in appearance to celecoxib capsule, containing corn starch

Trial Locations (1)

Unknown

Ivan Hung, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT02108366 - Treatment of Severe Influenza A Infection | Biotech Hunter | Biotech Hunter